Pages without language links

Jump to navigation Jump to search

The following pages do not link to other language versions.

Showing below up to 199 results in range #201 to #399.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Moc-up page
  2. Moc technical committee
  3. Modality Committee Archive
  4. Monthly FDG-PET Call Summaries
  5. Myocardial Blood Flow Biomarker Committee
  6. NIST
  7. NM Coordinating Committee
  8. New Protocol Here
  9. Normalization Process
  10. Orphan Documents
  11. PDFF Biomarker Committee Call Summaries
  12. PDFF Biomarker Committee Call Summaries Archive
  13. PDFF Biomarker Ctte
  14. PDF BC Call Summaries Archive
  15. PET Amyloid BC Call Summaries Archive
  16. PET Amyloid Biomarker Ctte
  17. PET Myocardial Blood Flow Biomarker Committee
  18. PET Myocardial Blood Flow Call Summaries
  19. PET Myocardial Blood Flow Call Summaries Archive
  20. PET Tau Biomarker Committee
  21. PUBLIC COMMENT WORK PAGE
  22. Perfusion, Diffusion and Flow-MRI Biomarker Ctte
  23. Perlman Advisory Group
  24. Phantom Development
  25. Phantom Development Subcommittee
  26. Phantom Development Technical Subcommittee
  27. Phantom Protocol & Data Analysis
  28. Phantoms And Tests Subcommittee
  29. Pharma Imaging Network for Therapeutics and Diagnostics (PINTAD)
  30. Pilot Conformance Projects Under Development
  31. Process
  32. Process Committee Agenda Archive
  33. Process Committee Call Summaries
  34. Process Committee Call Summaries Archive
  35. Process Coordinating Committee
  36. Process Education
  37. Proffered Protocols
  38. Profile: CT Lung Nodule - Small Nodule in Neoadjuvant Setting
  39. Profile: CT Lung Nodule - Small Nodule in neoadjuvant Setting
  40. Profile: CT Lung Nodule Response
  41. Profile: CT Lung Nodule Volume Change for Primary, Hilar and Medistinal Lymph Nodes
  42. Profile: CT Lung Nodule Volume Measurement for Primary/Regional Nodes and Metastatic Sites
  43. Profile: FDG-PET Whole Body
  44. Profile Conformance
  45. Profile Development
  46. Profile Editions
  47. Profile Strategy for Vol CT
  48. Profile drafts
  49. Profiles
  50. Project (19a): Validation of Breath Hold Task for Assessment of Cerebrovascular Responsiveness and Calibration of Language Activation Maps to Optimize Reproducibility
  51. Project 1a: Inter-scanner/ Inter-clinic Comparison of Reader Nodule Sizing in CT Imaging of a Phantom
  52. Project 2a: Assessing Measurement Variability of Lung Lesions in Patient Data Sets
  53. Project 2a: Assessing Measurement Variability of Lung Lsions in Patient Data Sets
  54. Projects
  55. Proposed Changes to Acquisition Protocol -- 20090315 - E Jackson
  56. Public Comment Process
  57. Publication Process
  58. Pulse-Echo Quantitative Ultrasound (PEQUS) Call Summaries
  59. QIBA/RIC ctte
  60. QIBA / QuIC-ConCePT Call Summaries
  61. QIBA Acknowledgments
  62. QIBA Artificial Data Evaluation Software
  63. QIBA COPD/Asthma Committee
  64. QIBA Collaborations
  65. QIBA Communications Committee Call Summaries Archive
  66. QIBA Concepts
  67. QIBA Conformance Statement Template
  68. QIBA DCE-MRI Technical Committee Call Summaries
  69. QIBA FDG-PET/CT SUV Subcommittee Site
  70. QIBA Informational Meeting (Dec 1st at RSNA 2008) - Slide Content Review
  71. QIBA Kiosk Content Review
  72. QIBA Leadership Reference Materials
  73. QIBA Leadership Slides
  74. QIBA Modality Committees
  75. QIBA News
  76. QIBA Newsletter Archive
  77. QIBA Overview
  78. QIBA PDF-MRI Biomarker Committee Call Summaries Archive
  79. QIBA PDF-MRI Technical Committee Call Summaries
  80. QIBA PET Amyloid Biomarker Committee Call Summaries
  81. QIBA Planning Committee
  82. QIBA Posters from RSNA Annual Meetings Archive
  83. QIBA Profile Conformance
  84. QIBA Profile Drafting Process
  85. QIBA Profile Stages
  86. QIBA Profile Template
  87. QIBA Protocol/Profile Implementation Feedback Process
  88. QIBA Sustainability Implementation Committee (QSIC)
  89. QIBA Ultrasound SWS Call Summary Archive
  90. QIBA Wiki Improvements
  91. QIBA and UPICT posters from RSNA 2009 Annual Meeting
  92. QIBA and UPICT posters from RSNA 2010 Annual Meeting
  93. QIBA and UPICT posters from RSNA 2011 Annual Meeting
  94. QIBA f-MRI
  95. QIBA fMRI Subcommittee Call Summaries
  96. QIBA for Imaging Vendors
  97. QIBA for Radiologists
  98. QIBA for Regulators
  99. QIBA for Statisticians
  100. QIBA for Technologists
  101. QIBA posters and plenary session presentation from RSNA 2011 Annual Meeting
  102. QIBA posters from RSNA 2012 Annual Meeting
  103. QIBA posters from RSNA 2013 Annual Meeting
  104. QIBA posters from RSNA 2014 Annual Meeting
  105. QIBA posters from RSNA 2015 Annual Meeting
  106. QIBA posters from RSNA 2016 Annual Meeting
  107. QIBA posters from RSNA 2017 Annual Meeting
  108. QIBA posters from RSNA 2018 Annual Meeting
  109. QIBA posters from RSNA 2019 Annual Meeting
  110. QIBA v-CT Chest
  111. QIBA vCT Lung Cancer Template (Editable)
  112. QIBA vCT Profile v1.1 edit site
  113. QIBA vCT Template
  114. Quality Control Metrics
  115. Quantitation Computation
  116. Quantitative-MRI
  117. Quantitative Computation
  118. Quantitative Response Metrics for Lung Cancer
  119. ROI Definition
  120. Reference Library
  121. Region of Interest (ROI) Definition
  122. Resources
  123. Retirement Process
  124. Review Process
  125. Revision for "What is a Profile?" as of 08.19.2011
  126. Roster
  127. SPECT BC Call Summaries Archive
  128. SPECT Biomarker Ctte
  129. SPECT Biomarker Ctte (proposed)
  130. SPECT Call Summaries
  131. SPECT TC99m BC Call Summaries Archive
  132. SWS Reporting and Results Transmission Subcommittee(no charge yet provided)
  133. SWS Reporting and Results Transmission Subcommittee (no charge yet provided)
  134. Scratch Page for CT Volumetry
  135. Segmentation and Markup Formats
  136. Selection Process
  137. Small Lung Nodule BC Call Summaries Archive
  138. Software Version Tracking
  139. Stakeholder Contacts
  140. Stakeholder Viewpoints
  141. Standardized Uptake Value (SUV)
  142. Steering Committee
  143. Steering Committee Call Summaries Archive
  144. Submission Process
  145. Submitted Protocols
  146. Synthetic DCE-MRI Data
  147. System Dependencies Subcommittee
  148. TBN
  149. TC99m Biomarker Committee
  150. Technical Confirmation Process
  151. Test Page for Joe
  152. Test joe protocols
  153. The University of Texas M.D. Anderson Cancer Center
  154. Thoracic Imaging 2012 meeting informa
  155. Thoracic Imaging 2012 meeting information
  156. Tips for Extracting Protocols into the UPICT Template
  157. Tools and recommendation for structured literature review
  158. Trial Implementation Process-DRAFT PAGE
  159. UPICT
  160. UPICT Alzheimer's Disease/ Dementia Imaging Protocol Writing Group
  161. UPICT FDG-PET/CT Protocol Working Group
  162. UPICT Library
  163. UPICT Process
  164. UPICT TEST SITE - Modified
  165. UPICT Template
  166. US CEUS Call Summary Archive
  167. US Coordinating Committee
  168. US SWS Call Summaries Archive
  169. U Penn
  170. Ultrasound CEUS BC
  171. Ultrasound SWS Biomarker Ctte
  172. University of Colorado Denver, Department of Radiology
  173. University of Pennsylvania
  174. University of Washington
  175. University of Wisconsin
  176. User Page Template
  177. VU University Medical Center, The Netherlands
  178. VU University Medical Center, The Netherlands, Round-2
  179. Vetting Requirements
  180. VirtualScopics, Inc.
  181. VirtualScopics, Inc.- Software Development for Analysis of QIBA DCE-MRI Phantom Data
  182. Vol-CT - 1A Group Call Summaries
  183. Vol-CT - 1B Group Call Summaries
  184. Vol-CT 1C Group Call Summaries
  185. VolCT - Colorado Group
  186. VolCT - Group 1A
  187. VolCT - Group 1B
  188. VolCT - Group 1C
  189. VolCT - Group 2
  190. VolCT - Group 3A
  191. VolCT - Group 3B
  192. Volume Blood Flow Call Summaries
  193. Voting Privileges
  194. Voting Process
  195. What Are Profiles?
  196. What Are Profiles and Protocols?
  197. Wiki Accounts
  198. Work Product for Review
  199. Working Documents Archive

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)